首页> 外国专利> COMBINATION THERAPIES USING ANTI-METABOLITES AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS

COMBINATION THERAPIES USING ANTI-METABOLITES AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS

机译:使用抗肿瘤药物和靶向肿瘤相关性基质或肿瘤细胞的药物联合治疗

摘要

The present invention provides, inter alia, methods for treating or ameliorating the effects of a disease, such as cancer, in a subject. The methods include: administering to a subject in need thereof (a) a therapeutically effective amount of an agent selected from an anti-metabolite agent or analog thereof and combinations thereof; and (b) a therapeutically effective amount of a monoclonal antibody or antigen binding fragment thereof, wherein the monoclonal antibody contains: (i) a heavy chain variable region (VH), which includes an amino acid sequence selected from SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, and SEQ ID NO:7; and (ii) a light chain variable region (VL), which includes an amino acid sequence selected from SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, and SEQ ID NO:8. Compositions, including pharmaceutical compositions, and kits for treating diseases, such as cancer, are also provided herein.
机译:本发明尤其提供了用于治疗或改善受试者的疾病例如癌症的作用的方法。所述方法包括:向有需要的受试者施用(a)治疗有效量的选自抗代谢药物或其类似物及其组合的药物;和(b)治疗有效量的单克隆抗体或其抗原结合片段,其中所述单克隆抗体包含:(i)重链可变区(VH),其包括选自SEQ ID NO:1的氨基酸序列, SEQ ID NO:3,SEQ ID NO:5和SEQ ID NO:7; (ii)轻链可变区(VL),其包括选自SEQ ID NO:2,SEQ ID NO:4,SEQ ID NO:6和SEQ ID NO:8的氨基酸序列。本文还提供了包括药物组合物的组合物和用于治疗疾病例如癌症的试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号